Amarin Corp Gap fill possible.$amrn Terrible news for investors Things look really bleak this morning and may get a little worse before a notable reversal by RedHotStocks19
$AMRN found historical support Selling may be overdone as the algos kicked in after hours, where moves are always compounded by stop losses been hit. Will be on lookout tomorrow for a dead cat bounce at the minimum by Bullishcharts38
Financially good results are at stake technically ( AMRN )We have technically important points as support in a row 16, 15, then 14 14 are the last and most important support areas and we should not close below themby EHSANA2
Bull Target: $23My 1st level to watch is at the 100 reversed Fibonacci level. AMRN is expected to beat earnings guidance and enter profit territory for the first time. Bullish flag is forming.Longby TitaniumCapital6
$AMRN Maintains Bullish Breakout PotentialAMRN At the end of the day, this is a massive lateral consolidation in a breakout bullish trend. There are plenty of scenarios here that could lead to a takeout offer well above current levels given Vascepa's potential. Defined risk; undefined upside.Longby GregFolin4
AMRN breakout potential Looking for AMRN to break through 20 day MA on JPM conference and good market . See MACD and RSI charts look very promising Longby ketokat6
$AMRN to $17 for re-accumulationAmarin ready for a dive to at least $17 for institutional re-accumulation before violating thru resistance and making new highs to $30 this year. Temporary short which I will re-evaluate and flip after liquidity is taken from support areas. NASDAQ:AMRNShortby LEVERXYZ3
AMRN - Could Be A MonsterAmarin popped up on my daily scans that are showing bullish momentum following an oversold condition & I do like the look of its daily chart. A gap up on November 12th which has since been held. A Golden Cross occurring around the same time as well. I have a few price targets noted on the chart based on the Fibonacci Extension tool. What really interests me about this stock is the +32% short interest currently out on the stock. 1/3 of the 363 million outstanding shares are currently shorted. If this stock does continue its bullish momentum, then it is only a matter of time before the shorts have to cut loose. This thing can become a monster. I would definitely keep it on a watchlist at the very least.Longby Chartimistic6
Here 'l'll Let You in on a Little Secret:It's Called Gun and RunThat's what happened. Market makers pump up the share price in the premarket or in the after hours, then short it at artificially inflated prices to everybody in the morning. Think of it like an investment. You buy $2 million worth of stock for, let's say $25.00, then sell $20 million worth of stock for $26; then you cover when the price tanks in the morning. Of course nothing is guaranteed and it could go wrong, but the risk reward is very strong Those figures could be an exaggeration because I've never done it before and nor am I a market maker, but you get the jist. Nobody knows that by the way. Just letting you know. I found that out by pure chance, and maybe by the grace of god. by InteractiveSwingTradingUpdated 119
Nice SellI was trying to post the sell at $26 but tradingview had to load and everything was moving so fastby InteractiveSwingTrading4
$AMRN Alert set for break from channel in AmarinEntry level $9.44 = Traget price $9.75 = Stop loss $9.34 Short interest 13.02% Average analysts price target $27.60 | Overweight Company profile Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland. Longby Bullishcharts1136
Up 14% Since Alert. I Picked This Because...Huge following. During my spam endeavors, I noticed that the ticker AMRN would bring in several people; much more than was usual. I was always surprised by the large influx of visitors. That close was also very strong, and so was the daily. by InteractiveSwingTradingUpdated 8
AMRN looking for base breakout Good base here see if it can move higher from hereby J_ChartsUpdated 2
Strong EOD Buying. Medium Size, 1/2. Holding OvernightBig Following. Looking to sell morning spikeLongby InteractiveSwingTrading3
AMRN LONG: VWAP reclaim day trade not a swing trade target is 21AMRN had a downgrade and had an overreaction to the downgrade it held 20.00 support today. I think it will bounce to $21.00 PM or at open 11.21.19. This alert is only good for this as I don't have a bull or bearish view. I do believe it is worth around $30, I think its undervalued stock but this is a day trade. bought the close around 20.11 avg and a stop loss of 19.95 with a sell target at 21.00 if it reaches off the bat I will scale 50% off at 21.00 and see how it plays out. Longby UnknownUnicorn27761624
AMARIN LONG IDEA DAILY CHARTOk this stock idea doesnt fit my trading strategy.i was long from 16.7 to the first boom to 19s-20s and panick sold cause i had no idea where this was going to stop. FUNDUMENTALS.well no introductions needed.Its in a state of euphoria with analysts targets from 30to 50$. TECHNICALS.Now my reason for trading this.it seems to break over the all time high. My thinking is we could wait to see if this indeed breaks of the all time high.if it does we can open a trade with SL just bellow the support zone of 23-24 dollars and a TP level of 35 dollars?or maybe even higher. From purely R/R ratio i think its a bet im willing to takeLongby MarketSeamanUpdated 5
AMRN broke prior highsAMRN broke, held and had daily/weekly close above prior highs..monster move so far and a good sign for more IMO.Longby cghursh3
AMARIN - DAILY CHARTHi, today we are going to talk about Amarin Corporation and its current landscape. Amarin puts its Cardiovascular Drug named Vascepa to a key test today by the FDA committee. Back in 2012, the FDA initially approved Vascepa as the medication showed results in reduce triglyceride levels. Today the decision cames to determine if Amarin will be allowed to prescribe its medicament to reduce cardiovascular events. The approvement could be sharply bullish for the company considering that Cardiovascular diseases affect nearly half of Americans, as statics of the American Heart Associations. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.by Igor-Silva26
1st Published Idea - Amarin Fib AnalysisStarted swing trading a year ago and I find Fib. analysis to be very helpful. If I'm right, we should see a continual swing up to 17.20. Longby Sombro314Updated 3
AMRN - Getting That Heart PumpingAmarin had a gap down on July 18th that created an Island Reversal pattern. The stock saw another gap down on August 9th. AMRN has pulled back a couple of times after filling the gap creating a double-bottom & a base for the stock. Once again the stock price is testing the top of this fill level but with stochastics reading overbought I would expect another pullback. However, there is a bit of a bullish divergence in price to RSI noted on the chart. If we can see the next pullback be shallow, falling to around $15.50 - $16 before the next bullish move then I would be looking for an eventual breakout with prices rising to $20. There is another gap above that could lead to $21 in the future.Longby ChartimisticUpdated 6